{
  "id": "MSKCC_Motzer_Score_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2021-01-09",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To assist clinicians in discussions about prognosis for patients with metastatic RCC and can be used as a stratification factor in clinical trials.",
        "keywords": [
          "Renal Cell Carcinoma (RCC)",
          "Cancer ",
          "Metastatic "
        ],
        "use": "Use for estimating prognosis of patients with metastatic RCC. \nNote: Always correct calcium concentration for low albumin before scoring.\n\nMSKCC/Motzer Score variables and assigned points:  \n- Time from diagnosis to systemic treatment <1 year: No=0, Yes=1\n- Hemoglobin < Lower Limit of Normal: No=0, Yes=1\n- Calcium >10mg/dL (>2.5 mmol/L): No=0, Yes=1\n- LDH > 1.5x Upper Limit of Normal: No=0, Yes=1\n- Performance status <80% (Karnofsky): No=0, Yes=1\n\nMSKCC/Motzer Score formula: Addition of selected points, as above.\n\nMSKCC/Motzer Score: \nscore 0= Risk good = Median survival 20 months\nscore 1-2= Risk Intermediate= Median survival 10 months\nscore â‰¥3= Risk  High= Median survival 4 months\n\n",
        "misuse": "Not use for making decisions about treatment.",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17(8):2530-40.\n2. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 2002 Jan 1;20(1):289-96.\n3. Motzer RJ, Bacik J, Schwartz LH, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol. 2004;22(3):454-63.\n4. Mekhail TM, Abou-Jawde RM, Boumerhi G, Malhi S, Wood L, Elson P, Bukowski R. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol 2005 Feb 1;23(4):832-41.\n5. Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009;27(22):3584-90.\n6. Heng DY, Xie W, Regan MM, et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol. 2013;14(2):141-8."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.mskcc_motzer_score.v0",
        "template_id": "openEHR-EHR-OBSERVATION.mskcc_motzer_score.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          }
        }
      },
      "gt0008": {
        "id": "gt0008",
        "model_id": "openEHR-EHR-OBSERVATION.mskcc_motzer_score.v0",
        "template_id": "openEHR-EHR-OBSERVATION.mskcc_motzer_score.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0020]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0021]"
          }
        }
      }
    },
    "rules": {
      "gt0012": {
        "id": "gt0012",
        "priority": 4,
        "when": [
          "$gt0003|Time from diagnosis to systemic treatment <1 year|!=null",
          "$gt0004|Hemoglobin < Lower Limit of Normal|!=null",
          "$gt0005|Calcium >10mg/dL (>2.5 mmol/L)|!=null",
          "$gt0006|LDH > 1.5x Upper Limit of Normal|!=null",
          "$gt0007|Performance status <80% (Karnofsky)|!=null"
        ],
        "then": [
          "$gt0009|MSKCC/Motzer Score |.magnitude=$gt0003.value+$gt0004.value+$gt0005.value+$gt0006.value+$gt0007.value"
        ]
      },
      "gt0013": {
        "id": "gt0013",
        "priority": 3,
        "when": [
          "$gt0009|MSKCC/Motzer Score |<1"
        ],
        "then": [
          "$gt0010|Risk|='Favorable Risk Group'",
          "$gt0011|Median survival|='20 months'"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 2,
        "when": [
          "$gt0009|MSKCC/Motzer Score |>=1",
          "$gt0009|MSKCC/Motzer Score |<3"
        ],
        "then": [
          "$gt0010|Risk|='Intermediate Risk Group'",
          "$gt0011|Median survival|='10 months'"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 1,
        "when": [
          "$gt0009|MSKCC/Motzer Score |>=3"
        ],
        "then": [
          "$gt0010|Risk|='High Risk Group'",
          "$gt0011|Median survival|='4 months'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "MSKCC/Motzer Score",
            "description": "Memorial Sloan-Kettering Cancer Center (MSKCC/Motzer) Score for Metastatic Renal Cell Carcinoma (RCC)"
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Time from diagnosis to systemic treatment <1 year",
            "description": "Measured ~1 month after stopping anticoagulation"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Hemoglobin < Lower Limit of Normal",
            "description": "Men (Normal): 13.5-17.5 g/dL- Women (Normal): 12.0-15.5 g/dL"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Calcium >10mg/dL (>2.5 mmol/L)",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "LDH > 1.5x Upper Limit of Normal",
            "description": "Normal: 140 U/L"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Performance status <80% (Karnofsky)",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "MSKCC/Motzer Score ",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Risk",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Median survival",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "MSKCC/Motzer Score"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "score 0 interpretation"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "score 1-2 interpretation"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "score>=3 interpretation"
          }
        }
      }
    }
  }
}